Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriers

Manuscript Number: 

12-2227R1

Author(s): 
Marinus A. Blankenstein, Flora H. Duits, Maartje I. Kester, Peter G. Scheffer, Philip Scheltens, Charlotte E. Teunissen, Wiesje M. van der Flier

Disclosures

Marinus A. Blankenstein

  • Nothing to Disclose

Flora H. Duits

  • Nothing to Disclose

Maartje I. Kester

  • Nothing to Disclose

Peter G. Scheffer

  • Nothing to Disclose

Philip Scheltens

  • Grants
    • Agency: 
      GE healthcare
      Dates: 
      2012-2015

Charlotte E. Teunissen

  • Consulting Fees:
    Advisory Boards of Innogenetics and Roche
    Lecture Fees:
    Teva Denmark

Wiesje M. van der Flier

  • Nothing to Disclose